Home Products About Us Links Contact Us

D'Antonio Consultants International
5479 Lake Road,
Tully, NY 13159

Phone: 315-430-0282
Email: Click Here


Welcome to D'Antonio Consultants International, Inc

A Veteran Owned Business

The capabilities of the DCI team are diverse, and projects have ranged over a wide array of technologies. DCI focuses on research and development, specializing in electrical and mechanical engineering and prototyping services. We also provide final assembly, calibration and test for several products.

The DCI philosophy is to work in partnership with our customers so that critical product attributes are clearly defined early in the program. This promotes shorter development times, fewer prototypes and earlier marketing of new products. Relationship building and satisfying customer’s needs have been key to DCI’s success in obtaining and completing product development projects.

DCI Core Capabilities:

Analog and digital design
PCB design, FPGA design
Micro Controller Programming
Circuit Design
Model Shop:
Tool and Model making
Prototype development, fabrication, and testing
Purchasing and Manufacturing:
Sourcing and purchasing of electrical and mechanical components
Small scale manufacturing of specialty devices
Collaborative relationship with manufacturers for large scale manufacturing of medical, veterinary and other devices.
3D Computer Modeling
Design of devices, tools and fixture
Patents, Certifications and Contracts:
Writing and reviewing patents and contracts
Extensive experience with patent procedures and prosecution
Product certification to UL and CSA standards


In May, 2010 DCI successfully completed a human clinical trial officially titled, “A Clinical Study to Assess the Safety, Tolerability, and Immunogenicity of Licensed Seasonal Trivalent Influenza Vaccine Administered by Needle-Free Jet Injection Using LectraJet M3 RA in One Intramuscular Dose to Healthy Young Adults”.

The study was conducted in Baltimore, MD at the University of Maryland Center for Vaccine Development (CVD). Sixty healthy adult volunteers received a single lot, inactivated, licensed trivalent influenza vaccine (TIV), manufactured by Sanofi Pasteur, Fluzone®, by intramuscular (IM) administration.  Thirty volunteers received the injection using LectraJet, DCI’s Disposable Syringe Jet Injection (DSJI) system, and thirty by standard needle and syringe (NS).  Jet Injection (JI) of seasonal influenza vaccine using the newly licensed LectraJet M3 RA injector was well tolerated, immunogenic and safe, no related Serious Adverse Events (SAE) were reported.

There were no statistically significant differences between NS and JI for any of the measured immunogenicity endpoints.

For more information please refer to the ClinicalTrials.gov listing: http://www.clinicaltrials.gov/ct2/show/NCT00987350

DCI is pleased to announce that on December 24, 2009 the FDA approved DCI’s 510(k) submission for their LectraJet Needle-free Injection System.

© 2017 D'Antonio Consultants International, Inc. All Rights Reserved
Website Design and Hosting by Radical Webs Inc